Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,597,400
+$17,269,400 QoQ
Shares Held
2,045,000
+11.1% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
2.63%
of 13F equity value
Holder Rank
#23
of 293 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Casdin Capital, LLC holds $1,258,350,419 across 31 Biotechnology names. DNLI ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $482,682,924 | |
| 2 | RLAY |
Relay Therapeutics, Inc.
|
16,035,240 | $300,019,340 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
1,175,000 | $63,062,250 | |
| 4 | DNLI |
Denali Therapeutics Inc.
This page
|
2,045,000 | $52,597,400 | |
| 5 | NGNE |
Neurogene Inc.
|
1,545,361 | $48,601,603 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
1,350,000 | $46,332,000 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
665,000 | $36,575,000 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
843,857 | $25,180,692 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,597,400 | 2,045,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $35,328,000 | 1,840,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30,378,400 | 1,840,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,922,800 | 890,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,451,100 | 890,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,459,050 | 990,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,176,200 | 990,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,838,700 | 990,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,186,000 | 1,300,000 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $26,676,000 | 1,300,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,898,000 | 1,300,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $26,819,000 | 1,300,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,363,000 | 1,300,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $29,952,000 | 1,300,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,153,000 | 1,300,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $30,536,550 | 995,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $44,145,000 | 1,500,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $48,255,000 | 1,500,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,900,000 | 1,500,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $85,765,000 | 1,700,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $126,288,400 | 1,610,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $91,931,000 | 1,610,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $109,725,600 | 1,310,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $46,937,300 | 1,310,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $31,675,800 | 1,310,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $25,477,050 | 1,455,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||